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Abstract
Neural stem cells (NSCs) generate neurons throughout life in the hippocampal dentate gyrus
(DG). How gene expression signatures differ among NSCs and immature neurons remains largely
unknown. We isolated NSCs and their progeny in the adult DG using transgenic mice expressing a
GFP reporter under the control of the Sox2 promoter (labeling NSCs) and transgenic mice
expressing a DsRed reporter under the control of the doublecortin (DCX) promoter (labeling
immature neurons). Transcriptome analyses revealed distinct gene expression profiles between
NSCs and immature neurons. Among the genes that were expressed at significantly higher levels
in DG NSCs than in immature neurons was the growth factor insulin-like growth factor 2 (IGF2).
We show that IGF2 selectively controls proliferation of DG NSCs in vitro and in vivo through
AKT-dependent signaling. Thus, by gene expression profiling of NSCs and their progeny, we
have identified IGF2 as a novel regulator of adult neurogenesis.
INTRODUCTION
A number of neuro-psychiatric diseases such as epilepsy, stroke, age-related cognitive
decline, and depression result in neuronal loss or dysfunction (Zhao et al., 2008). The
discovery of neural stem cells (NSCs) in the adult brain that are proliferating and able to
generate functional neurons gave rise to the idea that neuronal loss could be ameliorated by
harnessing endogenous NSCs for brain repair (Lie et al., 2004; Suh et al., 2009). To achieve
this goal, NSCs first have to be characterized in detail and their developmental programming
must be better understood.
Under physiological conditions, the generation of substantial amounts of new neurons is
restricted to two brain areas: the subventricular zone (SVZ) lining the lateral ventricles (Lois
and Alvarez-Buylla, 1994) and the subgranular zone (SGZ) of the dentate gyrus (DG) in the
hippocampus (Kuhn et al., 1996). NSCs of both neurogenic regions share intrinsic stem cell
properties: when isolated and cultured in vitro, adult NSCs from the SVZ and DG are self-
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renewing, multipotent, and express several stem cell-associated proteins, such as the
transcription factor SRY-box2 (SOX2) (Palmer et al., 1995; Doetsch et al., 1999; Seaberg
and van der Kooy, 2002; Shi et al., 2004; Babu et al., 2007; Suh et al., 2007; Walker et al.,
2008). In addition, newborn neurons express the microtubuli-associated protein
Doublecortin (DCX), which is expressed for approximately 3 weeks after cells are born,
before they become functionally incorporated into the hippocampal or olfactory circuitry
(van Praag et al., 2002; Carleton et al., 2003; Jessberger and Kempermann, 2003;
Kempermann et al., 2004; Couillard-Despres et al., 2005).
Over the last decade, substantial progress has been made in identifying regulators of stem
cell activity and neuronal differentiation. It appears that a number of extrinsic and intrinsic
factors such as Wnt, Shh, BMP, and Notch control stem cell proliferation (Lai et al., 2003;
Lie et al., 2005; Breunig et al., 2007; Lugert et al., 2010; Mira et al., 2010). Similarly,
neuronal differentiation and maturation are regulated by intrinsic programs orchestrated
through transcription factors such as NeuroD1 and a number of external cues, among them
GABA and glutamate signaling (Ge et al., 2006; Tashiro et al., 2006; Gao et al., 2009).
Gene expression profiling of NSCs and their neuronal progeny holds the potential of
identifying novel and niche-specific regulators of neurogenesis; however, previous attempts
have failed to do so, either due to the sparseness of NSCs and newborn neurons within the
adult brain or because these studies have focused exclusively on NSCs or immature neuronal
populations (Pennartz et al., 2004; Beckervordersandforth et al., 2010).
In this study, we sought to identify novel regulators of adult neurogenesis by comparing
gene expression profiles of discrete cell populations representing either NSCs or immature
neurons. NSCs were isolated from transgenic mice expressing a GFP reporter under the
control of the Sox2 promoter (hereafter called SOX2+ cells), and immature neurons were
isolated from mice expressing a DsRed reporter under the control of the DCX promoter to
isolate immature neurons (hereafter called DCX+ cells) (Couillard-Despres et al., 2006; Suh
et al., 2007). Using this approach, we identified novel and selective regulators of distinct
steps in the developmental course of adult hippocampal neurogenesis, thereby providing the
first gene expression-based analysis of adult hippocampal neurogenesis.
MATERIALS AND METHODS
Fluorescence activated cell sorting (FACS)
Two previously described transgenic mouse lines were used for FACS sorting of SOX2+
and DCX+ cells: one line expressed GFP under the Sox2 promoter and the other line
expressed DsRed under the Dcx promoter (Couillard-Despres et al., 2006; Suh et al., 2007).
For each experiment, the DGs of 10 hippocampi were dissected and pooled from 6- to 8-
week-old mice. Dissected tissue was chopped into ~1 mm3 pieces using sterile razor blades
and dissociated by incubation for 30 minutes in a solution containing 0.01% papain (25 U/
mg, Worthington Biochemicals), 0.1% neutral protease (0.5 U/mg, Roche), and 0.01%
DNaseI (2788 U/mg, Worthington Biochemicals). The cell suspension was mixed with an
equal volume of DMEM:F12 media (containing 1 mM L-glutamine and 10% fetal bovine
serum) and filtered through a 70-μm nylon mesh, mixed with an equal amount of Percoll
solution and pelleted (20,000 g for 30 minutes). Cellular debris was removed, and cells were
spun down and dissolved in 2 ml DMEM:F12 plus N2 supplement. For FACS, GFP was
excited with a 488-nm water-cooled argon laser; DsRed was excited with a 561-nm solid-
state laser. The filters used were 530/30 nm for GFP and 630/22 nm for DsRed using a BD
FACSvantage Diva system (BD Biosciences). Three independent FACS experiments were
performed for each cell type.
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Microarray analysis
RNA from 1,000 cells from each cell population was isolated with TRIzol reagent
(Invitrogen), amplified and reverse transcribed using the SuperAmp protocol (Miltenyi).
cDNA was hybridized on 44 K mouse whole genome arrays (Agilent). The integrity of the
cDNA was validated with the Agilent 2100 Bioanalyzer (Agilent). Raw Cy3 data were
normalized to the median and all values that were smaller than 1 were set to zero. All genes
that had zero values in at least 5 of 6 arrays were deleted from the list, leaving 29,148 genes
for analysis. Data were analyzed using the CARMA software suite
(https://carmaweb.genome.tugraz.at/carma/) (Rainer et al., 2006). The values were log2
transformed and quantile normalized. Expression differences were calculated over 3
replicates between 2 groups of experiments with the LIMMA package employing a modified
t-statistic. The Benjamini and Hochberg false discovery rate was used to calculate p-values.
The final gene lists contain all genes with a p-value <=0.05. Expression values of genes that
were represented more than once on the array were averaged. Heatmaps were generated
using the statistics software R (R Development Core Team, 2008) using the heatmap.2
method implemented in the gplots package (www.rosettabio.com/products/resolver). Array
data are availaible online at the Gene Expression Omnibus (GSE21208;
www.ncbi.nlm.nih.gov/geo). Gene Ontology classification and pathway analyses were
performed using the MetaCore software package (www.genego.com/metacore).
Quantitative PCR
Two methods for quantitative PCR (qPCR) experiments were used: SYBR Green and
TaqMan. cDNA was synthesized using the SuperAmp protocol (Miltenyi). qPCR was
performed either with a Power SYBR Green PCR Master Mix on an ABI Prism 7000
Sequence Detection System (Applied Biosystems) or with a TaqMan® PCR Master Mix
(Applied Biosystems) on an ABI Prism 7900HT Sequence Detection System (Applied
Biosystems). All qPCR reactions were performed using the same protocol (50°C, 2 min;
95°C, 10 min for 1 cycle; 95°C, 30 s; 60°C, 1 min for 40 cycles). All qPCRs were done in
biological and technical triplicates. Data were analyzed using the SDS2.1 software package
(Applied Biosystems) and Microsoft Excel. GAPDH was used as an endogenous
normalization control and the fold expression relative to GAPDH was determined by the
delta-delta Ct method. All primer sequences used are available upon request. We used the
Student's t-test to test for significance.
Cell culture and constructs
We isolated NSCs from micro-dissected DG and SVZ of 6- to 8-week-old adult mice as
described previously (Ray and Gage, 2006). shRNA oligos were cloned into the original
LentiLox3.7 vector (Addgene), which contains an U6-driven cloning site and a CMV-driven
GFP or a modified vector containing an U6-driven cloning site and a CMV-driven mCherry.
Target sequences were CCAAAGAGCTCAAAGAGTT and
GGACCGCGGCTTCTACTTCAGT (Zhu et al., 2007). As a control, we used vectors
expressing an shRNA that does not have a murine target (non-targeting shRNA,
CCTAAGGTTAAGTCGCC). Coding sequences for AKT (Addgene plasmid #9021) and
dominant-active AKT (AKTdPH, Addgene plasmid #9009) were cloned into retroviral
vectors as described previously (Jessberger et al., 2008). To test the efficiency of shRNAs to
knockdown IGF2 protein levels, 293T cells were collected in standard RIPA buffer 48 hours
after transfection with Igf2-overexpressing and shRNA constructs using Lipofectamine 2000
(Invitrogen). Knockdown of IGF2 protein was analyzed by Western blots as described
previously (Jessberger et al., 2008). For rescue experiments IGF2 (20 ng/ml, Biotrend) was
added to the culture medium 1 day after lentiviral transduction for 2 days before
proliferation analyses. The peptide analog of IGF-I, JB1 (Bachem Biosciences), was used to
block IG1R function. JB1 (1 μg/ml) was added to the culture medium 1 day after virus
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transduction. Two days after JB1 application, EdU was added to the culture medium for 1
hour to measure proliferation rate.
For phosho-protein Western blots, the RIPA buffer contained a mix of phosphatase
inhibitors (Phosphatase Inhibitor Cocktail 1 and Phosphatase Inhibitor Cocktail 2, Sigma).
Protein was isolated from mouse DG and mouse SVZ stem cell cultures either under
proliferation or differentiation conditions (2 days for proliferation; 2 weeks for
differentiation by growth factor withdrawal). Cells were infected with lentiviruses 1 day
after plating and lysed using RIPA buffer containing protease inhibitors (Complete mini
EDTA-free, Roche). Proteins were separated by SDS-PAGE on a 4–12% Bis-Tris gradient
gel (Invitrogen) and transferred to a nitrocellulose membrane (BIO-RAD). Membranes were
probed overnight using mouse α-pAKT (Cell Signaling), rabbit α-AKT (Cell Signaling),
rabbit α-pIRS-1 (Cell Signaling), rabbit α-IRS-1 (Cell Signaling), or goat α-IGF-2 (Santa
Cruz). HRP-conjugated secondary antibodies or AP-conjugated antibodies (Promega) were
used at 1:4000 dilutions. Bands were detected by enhanced chemiluminescence substrate
(Millipore) or CDS-Star substrate (Roche).
The levels of IGF2 in murine NSC cultures were measured using the Mouse IGF-II DuoSet
(R&D Systems) ELISA kit, according to the manufacturer's instructions. IGF2 samples were
taken from mDG/mSVZ and differentiated mDG stem cell cultures. Lysates were extracted
using RIPA buffer and medium was first concentrated using Amicon Ultra centrifugal filter
devices (Millipore) prior to measurement. Serial dilutions of IGF2 standard were assayed in
parallel with lysates and culture medium samples. IGF2 concentration was expressed as pg/
ml of lysate or culture medium. The optical density was plotted against standard IGF2
concentrations to generate the standard curve, according to the manufacturer's protocol.
Samples were read at 450 nm using a SpectraMax 190 Absorbance Microplate Reader
(Molecular Devices). For proliferation experiments, cells were pulsed for 1 hour with 10
μM EdU (Invitrogen) and then fixed. EdU was visualized according to the manufacturer's
protocol (Invitrogen). To analyze the mode of IGF2 action, we transduced NSCs using
lentiviruses expressing shRNA against Igf2 with varying virus titers, thus leading to the
infection of NSC cultures in different concentrations with transduced and non-transduced
cells in the same culture dish. For differentiation, growth factors were withdrawn and cells
were kept in DMEM:F12 plus heparin for 14 days (see above). For all virus-mediated Igf2
knockdown experiments in vitro, 25 fields per coverslip (n ≥ 3) were imaged using a 40×
objective on an inverted microscope (Zeiss Axiovert Observer-D1). GFP+ and EdU+ cells
were counted using ImageJ (colocalization and cell counter plug ins, NIH). Approximately
2,000 GFP+ cells were counted per condition in the DG NSC proliferation assay and in the
rescue experiment using 20 ng/ml IGF2 as a supplement. Approximately 1,500 cells were
counted for the proliferation assay of SVZ NSCs. Approximately 1,000 cells per condition
were analyzed for the differentiation experiments. In the rescue experiment using a virus to
overexpress AKT together with Igf2 knockdown or control viruses approximately 400 DG
NSCs were counted per condition. In the IGF1R inhibition experiment using the
pharmacological inhibitor JB1 (1 ug/ml), approximately 800 GFP+ cells were counted. For
the dilution series experiments, approximately 6,000 DAPI+ cells were counted per
condition. GFP+ cells were calculated by subtracting the GFP− cells from the total DAPI+
cells. The GFP+EdU+ cells were calculated by subtracting the total GFP−EdU+ cells from
the total EdU cell number.
Animals and immunostaining
Female mice were used for all immunohistochemical experiments: WT (C57Bl/6) were 6 to
8 weeks old and nestinGFP transgenic mice were 8 weeks old (Yamaguchi et al., 2000). All
protocols were approved by the Salk Institute's Institutional Animal Care and Use
Committee (IACUC) or by the veterinary office of the Canton of Zurich. For knockdown of
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IGF2, animals were injected with lentiviruses (two shRNAs targeting Igf2 mRNA, one non-
targeting, control shRNA) into the DG (coordinates from Bregma a/p −2.0, m/l, ± 1.5, d/v
−2.3 from skull or for SVZ a/p −1.0, m/l ± 1.0, d/v −2.8 from skull). Three weeks after viral
injections, animals received one injection of IdU (87 mg/kg bodyweight) and were killed 24
hrs later. Tissue was processed for immunostaining as described earlier (Jessberger and
Kempermann, 2003). Briefly, brains were cut into 40-μm thick sections and distributed into
12 series. One series from each brain (n ≥ 3) was stained and used for counting cell
numbers. All countings were done using serial scanning microscopy. For all combinations
analyzed, ≥ 50 cells per animal (with a n ≥ 3) were phenotyped for the expression of the
respective markers. For intensity measurement, images were taken with a Leica SP2
confocal fluorescence microscope, using the same settings for all conditions. All sections
were stained and imaged in parallel. IGF2 staining fluorescence intensity was measured and
calculated using ImageJ (NIH). Immunostaining intensity was measured over the virus-
infected area and normalized to the intensity of the non-targeting shRNA. Integrated density
measurements of the control were set to one.
Primary antibodies used were rat α-BrdU (Harlan Seralab), mouse α-BrdU (Becton
Dickinson; for IdU detection), rabbit α-GFP (Molecular Probes), chicken α-GFP (Aves),
rabbit α-SOX2 (Chemicon), goat α-SOX2 (Santa Cruz), goat α-DCX (Santa Cruz), rabbit
α-DCX (Cell Signaling), mouse α-GFAP (Chemicon), goat α-IGF2 (Santa Cruz), and rabbit
α-Ki67 (Novacastra). All secondary antibodies were from Jackson ImmunoResearch.
Fluorescent signals were detected using two different spectral confocal microscopes
(Radiance 2100, Bio-Rad, and Leica SP2, Leica). Nuclei of cells and tissues were
counterstained with 4–6-diamidino-2-phenylindole (DAPI, Sigma). Images were processed
in Adobe Photoshop (CS5 for Mac) for general contrast enhancements and color
adjustments.
In situ hybridization
Single-stranded RNA probes against Igf2 mRNA were generated by in vitro transcription of
a full-length Igf2 cDNA (Open Biosystems plasmid MMM1013-9201704) using T7 or Sp6
RNA polymerase in the presence of digoxigenin (DIG)-UTP. The hybridization procedure
was performed according to standard procedures (Wilkinson, 1998).
Statistical analyses
All numerical analyses were performed using Excel (Microsoft) or SPSS (IBM). Two
sample t-tests or ANOVA (if applicable) were used for all comparisons. Differences were
considered significant at p < 0.05.
RESULTS
FACS-based isolation and transcriptome analyses of SOX2+ and DCX+ cells from the adult
DG
We micro-dissected the DG of transgenic mice that were either expressing GFP under the
control of the Sox2 promoter or DsRed under the control of the Dcx promoter (Couillard-
Despres et al., 2006; Suh et al., 2007), and we subsequently performed FACS for SOX2+
and DCX+ cells (Figure 1A, B). We used the resultant cell populations for RNA preparation
and performed microarray hybridization experiments. To identify differentially regulated
genes, we employed statistical analysis of microarray data (see Materials and Methods).
Only genes that were found to be significant after multiple testing corrections (Benjamini
and Hochberg; p < 0.05) were included in the analyses. We validated a set of differentially
regulated genes with quantitative PCR (qPCR) (Figure 1C, D). The array and qPCR
expression data were in agreement for all tested genes, with a generally high concordance
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between fold-changes calculated from the array and from qPCR analyses (data not shown).
Cluster analyses of differentially expressed genes revealed the high reproducibility of the
biological triplicates (Figure 1E).
Analyses of gene expression data showed that 1,494 genes (3.4% of all transcripts
interrogated) were differentially regulated between SOX2+ and DCX+ cells in the DG. Of
these, 840 genes (~ 56%) were upregulated and 654 genes (~ 44%) were downregulated in
DCX+ cells compared to SOX2+ cells. The top 10 regulated genes are shown in Figure 1F.
We employed gene annotation analysis of Gene Ontology (GO) terms to identify pathways
and processes of regulated genes that had a significant enrichment of regulated genes within
the DG. We found that, among others, the GO classes of developmental processes and cell
differentiation were significantly enriched in SOX2+ cells (Figure 1G). In DCX+ cells, we
found GO terms of genes enriched that are associated with nervous system development,
neurogenesis, generation of neurons, and neurite development. Among the highly expressed
genes in DCX+ cells were previously identified regulators of differentiation such as
Stathmin 1 (Stmn1), a cytosolic phosphoprotein that plays an important role in regulating
microtubule dynamics in the context of mitosis as well as neuronal migration (Peschanski et
al., 1993). Another example is Prox1, which has recently been identified to be critical for
neuronal differentiation of hippocampal granule cells (Lavado et al., 2010; Karalay et al.,
2011). In total, we found that approximately 31% of the genes that were expressed more
highly in DCX+ cells had been previously associated with neurogenesis or differentiation,
thus supporting the validity of the gene array data. In analogy, we found that approximately
29% of all genes overexpressed in SOX2+ cells had been previously implicated in stem cell
activity or cell proliferation.
Surprisingly, we also found many genes enriched in SOX2+ cells enriched in GO classes
associated with generation of energy, lipid metabolism and catabolic processes, which might
point toward a previously unrecognized metabolic program of DG NSCs. For example, we
found 12 genes enriched in SOX2+ cells that were annotated in the GO term regulation of
lipid metabolic process (GO 0019216), among them Bmp6, Apoe, Acacb, Igfbp7, Edf1, Irs,
Lrp1, Cpt1a, Pparc1a, Acaa2, and Acsl6.
IGF2 is highly expressed in NSCs in the DG
We next sought to characterize the functional significance of a gene that is highly expressed
in the SOX2+ cell population in the DG. We focused our analyses on IGF2, which we
identified to be highly expressed in SOX2+ cells compared to DCX+ cells (~60-fold; Figure
2A). This expression profile, together with previous data showing that the growth factor
IGF2 plays an important role during embryonic development and has been implicated in
sonic hedgehog (Shh)-mediated cell proliferation and cancer (Toretsky and Helman, 1996;
Hartmann et al., 2005), made IGF2 an intriguing candidate for a regulator of hippocampal
neurogenesis. After confirming the array data by qPCR (Figure 2A), we performed in situ
hybridization using probes directed against Igf2 mRNA and found an enrichment of Igf2
mRNA in the SGZ, the site within the DG that harbors NSCs and immature neurons (Figure
2B and data not shown). In support of the mRNA expression, we detected high expression
levels of IGF2 protein in the SGZ with higher expression in SOX2+ cells compared to DCX
+ cells in the DG (Figure 2C, D), corroborating the array- and mRNA-based Igf2 gene
expression results. This finding also confirmed previous reports that showed Igf2 expression
in the postnatal DG (Zhang et al., 2007). We next characterized the expression of IGF2 in
more detail based on previously described markers of NSCs in the adult DG (Seri et al.,
2001; Kronenberg et al., 2003; Suh et al., 2007). We found that IGF2 was highly expressed
in radial glia-like NSCs expressing SOX2GFP, nestinGFP, or glial fibrillary acidic protein
(GFAP) and that a substantial fraction of dividing (Ki67+) cells co-labeled with IGF2
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(Figure 2E, F). Thus, the gene expression profiling strategy we employed correctly
identified IGF2 to be highly enriched in a NSC population within the adult DG.
IGF2 regulates proliferation of hippocampal NSCs in vitro
To test the functional importance of Igf2, we isolated NSCs from the adult DG and analyzed
IGF2 protein levels in vitro. Independent array data obtained from SOX2+ cells from the
SVZ indicated that IGF2 was only enriched in SOX2+ cells from the DG but not in SOX2+
cells isolated from the SVZ. Thus, we isolated in parallel NSCs from the adult SVZ.
Confirming the gene expression profile, Western blots and ELISA showed that IGF2 protein
was strongly enriched in DG-derived NSCs compared to NSCs derived from the SVZ
(Figure 3A, B). Further, IGF2 was substantially downregulated with differentiation of NSC
cultures, as measured by total protein amount and protein levels in the supernatant by
ELISA (Figure 3A, C).
We next tested whether knockdown of Igf2 would affect NSC behavior in a cell-type
specific manner. We transduced cells in vitro with lentiviruses expressing 2 different
silencing short-hairpin RNAs (shRNAs) directed against Igf2 mRNA (Figure 3D). When we
measured proliferation rates of DG-derived NSCs with 5-ethynyl-2-deoxy-uridine (EdU)
pulse labeling or by staining for Ki67, we found that IGF2 knockdown significantly
decreased proliferation (Figure 3E and data not shown). Notably, Igf2 knockdown was not
associated with enhanced apoptosis of NSCs in vitro, as measured by TUNEL assay (data
not shown). Further, we found that reduced proliferation after Igf2 knockdown of DG-
derived NSCs was fully rescued by the addition of exogenous IGF2 (Figure 3E), whereas
addition of IGF2 to control cells had only a minor effect on NSC proliferation (data not
shown). As expected from the robust downregulation of IGF2 with differentiation, we did
not observe an effect of IGF2 knockdown on neuronal differentiation of either DG- or SVZ-
derived cells (Figure 3F). However, we did not find an effect on proliferation in SVZ-
derived NSCs after knockdown of Igf2 suggesting that production of IGF2 is only critical
for SOX2+ NSCs derived from the adult DG (Figure 3G).
In conclusion, these data suggest that IGF2 plays a role in the proliferation of NSCs derived
from the adult DG in vitro.
IGF2 regulates NSC proliferation via AKT signaling in a largely autocrine manner
We next sought to characterize the signaling pathways through which IGF2 might regulate
proliferation of DG-derived NSCs. Pathway analyses of our gene expression profiles (data
not shown) and previously published reports suggested that IGF2 might act via v-akt murine
thymoma viral oncogene homolog 1 (AKT) to regulate NSC proliferation (Hartmann et al.,
2005; Peltier et al., 2007). To dissect the molecular mechanisms underlying the effects of
IGF2 on stem cell behavior, we focused on the role of AKT-dependent signaling. We found
that levels of phospho-AKT (pAKT) were significantly downregulated with neuronal
differentiation, supporting a role for AKT signaling in NSC proliferation (Figure 4A).
ShRNA-mediated knockdown of Igf2 led to a reduction in insulin receptor substrate 1 (IRS)
phosphorylation, an intracellular adaptor protein that becomes phosphorylated upon IGF-
receptor activation (Sun et al., 1991), and a reduction in pAKT levels (Figure 4B, C). In
addition, we found that the phenotype of Igf2 knockdown (i.e., impaired proliferation) was
rescued by overexpression of a dominant-active AKT (Figure 4D). Taken together, these
data suggest that IGF2 acts via AKT-dependent signaling to regulate proliferation of
hippocampal NSCs.
We next analyzed whether IGF2 functions via an IGF1 receptor (IGF1R) or IGF2 receptor
(IGF2R). Although, most data suggest that IGF2R does not transduce a signal but rather
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sequesters the activity of IGF2 away from the IGF1R (for a review see Pollak, 2008),
recently published evidence has suggested that IGF2R might be able to mediate IGF2-
dependent signaling (Chen et al., 2011). We used a IGF1R-specific blocking peptide (JB1)
(Pietrzkowski et al., 1992) and found that inhibition of IGF1R strongly reduced NSC
proliferation, exceeding the effect of IGF2 knockdown alone (Figure 4E). In addition, IGF2
knockdown did not further decrease NSC proliferation after JB1 treatment, suggesting that
IGF2 functions via the IGF1R but also that additional growth factors (such as IGF1) may act
on the IGF1R to regulate NSC proliferation.
To test if IGF2 functions predominantly in an autocrine manner, we co-cultured NSCs
transduced with shRNA-expressing viruses in distinct ratios together with nontransduced
cells. Notably, we found that only high ratios of IGF2-knockdown cells (>90% of all cells)
affected the proliferation on non-transduced NSCs, as measured with EdU pulse labeling
(Figure 5). In contrast, low ratios of IGF2-knockdown cells (< 25% of all cells) did not show
any effect on the proliferation on non-transduced NSCs (Figure 5). This finding suggests
that IGF2 largely functions in an autocrine manner but also exerts paracrine effects to
regulate hippocampal NSC proliferation.
Regulation of NSC proliferation by IGF2 in the adult brain
Next we analyzed whether the effects of IGF2 on NSCs that we observed in vitro also
occurred within the adult brain. We injected shRNA-expressing lentiviruses stereotactically
into the DG of adult mice and observed a significant drop in IGF2 protein levels within the
adult DG (Figure 6A, D). We next analyzed cell proliferation using the thymidine analog 5-
iodo-2-deoxy-uridine (IdU) 3 weeks after virus injections. In analogy to the in vitro
experiments, we found that IGF2 knockdown reduced proliferation of hippocampal NSCs
(Figure 6B). Corroborating the in vitro data, we found no effect of IGF2 knockdown on cell
proliferation in the adult SVZ (Figure 6C). Taken together, these results suggest that IGF2
acts as a regulator of adult hippocampal neurogenesis. Furthermore, this finding highlights
the usefulness of an unbiased gene expression profiling approach to reveal new molecular
mechanisms underlying life-long neurogenesis in the mammalian brain.
DISCUSSION
In this study we used reporter gene-assisted cell sorting of NSCs and immature neurons
isolated from the DG, a neurogenic zone in adult mouse brain, and subsequently performed
genome-wide transcriptome analysis of the different cell populations. We used the cell type-
specific markers SOX2+ and DCX+ to discern between NSCs and their neuronal progeny,
respectively. With this approach, we identified IGF2 as a novel niche-specific regulator of
neurogenesis that controls the proliferation of NSCs in the adult DG.
In addition, we identified a large number of genes that were previously implicated in stem
cell maintenance, proliferative activity or neuronal differentiation (for example Sox9, Cheng
et al., 2009; Reversion-inducing-cysteine-rich protein with kazal motifs (Reck), Muraguchi
et al., 2007; TAG-1, Furley et al., 1990; Smad interacting protein 1 (Sip1), Seuntjens et al.,
2009).
While these findings validate our strategy of combining reporter-based cell isolation with
microarray analysis, this approach is limited by the cell-type specificity of the markers we
used. While SOX2 expression is a hallmark of NSCs, a substantial fraction of classical
astrocytes is also positive for SOX2 (Couillard-Despres et al., 2006; Suh et al., 2007). In
fact, we found that approximately 30% of all SOX2GFP-expressing cells in the DG co-
labeled with S100ß which is not expressed in NSCs (data not shown). Furthermore, DCX
marks maturing cells ranging from neuroblasts to rather mature neurons of approximately 3
Bracko et al. Page 8
J Neurosci. Author manuscript; available in PMC 2012 September 07.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
weeks of age (Couillard-Despres et al., 2006; Suh et al., 2007); therefore, DCX+ cells also
represent a somewhat heterogeneous population. These limitations may have diminished or
even masked some differences in gene expression that might have been found with access to
perfectly homogeneous cell populations. Despite these limitations, we believe that our data
represent a useful resource for identifying and functionally testing genes in novel pathways
involved in neurogenesis. For example, we also found that EfnB3, one of the genes
identified to be upregulated in DCX+ cells of the DG, is functionally involved in the
survival of newborn hippocampal neurons (data not shown).
Gene expression analyses identify IGF2 as a regulator of DG neurogenesis
One of the genes we found to be highly expressed in the stem cells of the DG was Igf2. IGF
signaling has been shown to be involved in organ growth during embryonic development
(DeChiara et al., 1990; Sim et al., 2006; Ye and D'Ercole, 2006), and recent data suggest
that IGF1 is critically involved in brain development and NSC behavior (for a review, see
Joseph D'Ercole and Ye, 2008). Furthermore, IGF2 acts in concert with Shh signaling to
regulate proliferation of cerebellar progenitors (Fernandez et al., 2010). IGF2 appears to also
be important for the proliferation of medulloblastoma cells (Corcoran et al., 2008).
However, a role for IGF2 signaling in adult neurogenesis has not been demonstrated yet.
Our validation experiments confirmed high levels of Igf2 mRNA and protein in the DG and
we found that proliferation of DG-derived NSCs is regulated by IGF2 via IGF1R and AKT-
dependent signaling. Notably, our data indicate that IGF2 is mainly produced by SOX2+
NSCs and largely acts in an autocrine manner. This mode of IGF2 signaling seems to be
different from the second neurogenic area of the postnatal brain, where it has been recently
shown that Igf2 is expressed in the choroid plexus of the lateral ventricles and that IGF2
appears to modulate embryonic neurogenesis by being diffused through the cerebrospinal
fluid and by signaling through the IGF1R on SVZ NSCs (Lehtinen et al., 2011). Thus, it
appears that the same signaling factor, IGF2, although derived from different sources
(choroid plexus in the SVZ, SOX2+ NSCs in the DG), has similar effects on NSC
proliferation upon activation of IGF1R. This hypothesis is also supported by our findings
that FACS-based isolation of SOX2+ cells from the SVZ showed that SVZ-derived NSCs
expressed very low levels of IGF2 compared to SOX2+ cells in the DG. Furthermore,
knockdown of IGF2 in vitro or within the adult SVZ did not affect NSC proliferation.
Gene expression analyses followed by pathway mapping and our experimental data suggest
that IGF2 acts via AKT signaling to regulate proliferation of DG-derived NSCs. AKT
appears to be critically involved in cell survival and anti-apoptotic signaling throughout the
brain (Brazil et al., 2004). In addition, AKT has previously been implicated in precursor
proliferation of adult NSCs (Peltier et al., 2007). The molecular components downstream of
AKT activation that mediate NSC proliferation in the context of IGF2 signaling remain
unclear. However, it seems reasonable to speculate that AKT may serve as a hub to integrate
pro-proliferative signals (such as IGF2) with pathways that induce quiescence, such as BMP
or PTEN signaling (Groszer et al., 2001; Mathieu et al., 2008). Further studies are required
to understand the interplay between these signaling cascades in regulating the proliferative
behavior of hippocampal NSCs.
Harnessing endogenous NSCs for brain repair
Surveying gene expression profiles of NSCs of the adult brain and their progeny is an
important step in understanding the basic biology of adult neurogenesis. Notably, ongoing
neurogenesis in the adult brain has been implicated in a variety of diseases, and the
continuous generation of new neurons appears to play important roles for brain tissue
maintenance and brain function (Scharfman and Hen, 2007; Kempermann et al., 2008; Zhao
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et al., 2008). A thorough understanding of the molecular mechanisms underlying the
neurogenic process in the mature brain is therefore an important prerequisite to devising
strategies aimed at targeting NSCs for brain repair. Thus, the identification of mechanisms
regulating the activity of NSCs in the adult brain might prove a critical step for targeted
manipulation of NSC populations in certain diseases. By providing the molecular framework
for a deeper understanding of neurogenesis in the adult brain, the data provided in this work
will bring us closer to utilizing adult NSCs for endogenous brain repair.
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Figure 1.
Experimental strategy and expression of genes differentially regulated between NSCs and
their progeny. A, NSCs and their neuronal progeny were directly isolated from the adult DG
of SOX2GFP or DCXDsRed transgenic mice using FACS, followed by RNA isolation and
subsequent array hybridization (left). GFP and DsRed reporter expression in the adult DG
(right insets). B, FACS of adult hippocampal NSCs and their neuronal progeny.
Representative examples of FACS experiments using transgenic mice labeling SOX2GFP−
or DCXDsRed-expressing cells. Upper panel shows SOX2GFP-expressing cells isolated
from the DG. Lower panel shows DCXDsRed-expressing cells isolated from the DG. FL1-A
represents the GFP signal intensity, FL2-A represents the DsRed signal intensity. Boxed
areas show the cell population that was selected for RNA isolation. C, Verification of Sox2
and Dcx enrichment using qPCR. To verify the enriched expression of Sox2 and Dcx in
SOX2GFP− and DCXDsRed-expressing cells, we measured their expression levels using
quantitative PCR. Shown are the fold differences between SOX2+ and DCX+ cells (left
bars: Sox2 qPCR; right bars: Dcx qPCR). Data are presented as mean ± s.e.m. D,
Verification of array data using qPCR. To verify the array data, we picked 4 candidates out
of the top regulated genes from all comparisons and measured their expression levels using
quantitative PCR. Shown are the fold differences either to SOX2GFP− or DCXDsRed-
expressing cells within DG. Data are presented as mean ±s.e.m. Abbreviations: Klotho (Kl),
SRY (sex determining region Y)-box 9 (Sox9), Insulin like growth factor 2 (Igf2),
Calmodulin 4 (Calm4), Anilin (Anln), N-myc downstream regulated gene 1 (Ndrg1).
Stathmin 1 (Stmn1), EphrinB3 (Efnb3). E, Cluster analysis of differentially regulated genes
expressed in SOX2+ versus DCX+ cells indicates the high reproducibility of biological
triplicates. Red and blue denote high and low expression levels respectively. F, Top 10 up-
and down-regulated genes between SOX2+ and DCX+ cells of the DG. Regulation is
expressed as the relative difference in gene expression levels between SOX2+ and DCX+
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cells. G, Gene Ontology (GO) analysis of differentially regulated genes. All classes shown
were significantly enriched in their respective categories (p < 0.05).
Scale bars in A represent 100 μm. GCL, granule cell layer.
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Figure 2.
IGF2 is expressed in the SGZ of the DG. A, Quantitative RT-PCR shows strong enrichment
of Igf2 in SOX2+ cells of the DG compared to DCX+ cells. B, In situ hybridization using a
riboprobe against Igf2 mRNA shows expression in the granule cell layer (GCL) and an
enrichment of Igf2 mRNA in the SGZ of the DG. Hl, hilus; ML, molecular layer; GCL,
granule cell layer. C, IGF2 (red) shows high expression in SOX2+ cells (green) in the DG. A
high power view of a SOX2GFP/IGF2 co-expressing cell is shown on the far right
(arrowheads). D, IGF2 (red) shows only low expression in DCX+ cells (green). A high-
power view of a DCX+ cell (green) that does not co-label with IGF2 is shown on the far
right. E, Representative images of IGF2 expression (red) in co-stainings with GFAP (upper
panel, green), NestinGFP (lower panel, green), and Ki67 (lower panel, blue). Z-stacks show
3-dimensional reconstruction of IGF2/GFAP co-labeled cells (upper panel) and IGF2/
NestinGFP co-labeled cells (lower panel). F, Using confocal microscopy we quantified the
number of NestinGFP+, SOX2GFP+, GFAP+, and Ki67+ cells co-labeling with IGF2. We
found that a substantial fraction of radial-glia like cells in the DG expressed IGF2. Nuclei
were counterstained with DAPI. GCL, granule cell layer; Hl, hilus; ML, molecular layer.
Data are presented as mean ± s.e.m. Scale bars represent 100 μm (C and D) 50 μm (E).
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Figure 3.
IGF2 regulates proliferation of DG NSCs in vitro. A, Enzyme-linked immunosorbent assays
(ELISA) for IGF2 were performed. Medium from proliferating DG and SVZ NSCs and
from 14-day differentiated DG NSCs was collected, concentrated and analysed. Graph
shows the amount of Igf2 in the medium in pg/ml normalized to total protein (mg/ml). B,
IGF2 protein levels are higher in DG-derived NSCs than in SVZ-derived NSCs. Total
protein was isolated from proliferating NSCs isolated from DG or SVZ. Western blot
analysis showed higher protein levels of IGF2 in DG- than in SVZ-derived cultures. C, IGF2
is down-regulated with differentiation of DG-derived NSCs. Shown is a representative
Western blot and quantification of relative protein levels. D, DG cells were infected with
lentiviruses expressing different shRNA sequences targeting Igf2 mRNA. shRNA sequences
sh1 and sh2 resulted in approximately 75% and 60% decreases in IGF2 protein levels,
respectively. Shown are representative Western blots with non-targeting shRNA (CON) or
shRNA against Igf2. E, Knockdown of IGF2 using two independent lentiviruses expressing
shRNAs (Igf2-sh1 and Igf2-sh2) targeting the murine Igf2 mRNA resulted in a robust
decrease in the number of proliferating, EdU-labeled, DG-derived NSCs in vitro (upper
panels, red). Exogenous IGF2 rescued the proliferation defect caused by knockdown of
endogenous IGF2 knockdown. IGF2 supplementation (20 ng/ml IGF2) rescued the
proliferation phenotype (as measured by EdU incorporation, lower panels, red) of IGF2
knockdown in DG-derived NSCs. Panels show representative pictures of cells transduced
with a lentivirus expressing non-targeting shRNA (CON, green, left panels) or expressing
shRNA sequence 1 (Igf2-sh1) or 2 (Igf2-sh2). Arrowheads point to GFP-expressing, EdU-
labeled cells. Data are presented as mean ± s.e.m. Scale bars in the images represent 50 μm.
F, After transduction with viruses expressing shRNAs directed against Igf2 or non-targeting
control shRNA, NSCs were differentiated for 14 days. There was no effect on the number of
MAP2ab/GFP+ cells compared to control. Shown are examples and the quantification of
GFP (virus-expressing, green) and MAP2ab (red) co-labeled cells in DG NSC cultures.
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Nuclei were counterstained with DAPI (blue). Data are presented as mean ± s.e.m. Scale bar
represents 100 μm. *p < 0.05. G, IGF2 knockdown did not affect the number of EdU-
labeled cells in NSC cultures derived from the adult SVZ. Right panels show representative
pictures of cells transduced with a non-targeting shRNA expressing lentivirus (CON, green,
left panels) or expressing shRNA sequence 1 (Igf2-sh1) or 2 (Igf2-sh2) (green, middle and
right panels). Arrowheads point toward GFP-expressing, EdU-labeled cells. Scale bar
represents 50 μm.
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Figure 4.
IGF2 acts via AKT signaling to regulate NSC proliferation. A, Levels of pAKT are
dynamically regulated with differentiation of NSCs, suggesting a role for pAKT signaling in
NSC proliferation. B, Knockdown of IGF2 decreases IRS1 phosphorylation. C, Knockdown
of IGF2 results in decreased AKT phosphorylation levels. A–C show representative Western
blots and densitometric quantification. Data are normalized to total AKT (A, C) or total
IRS1 (B). D, Virus-mediated overexpression of AKT (green) in NSCs rescues the
proliferation defect as measured by EdU labeling (blue) caused by IGF2 knockdown
(control and shRNA-expressing virus in red). Arrowheads point to EdU/GFP/mCherry-
labeled cells. Bars show quantification of NSC proliferation. E, Virus-mediated knockdown
of IGF2 (control and shRNA-expressing viruses in green) together with blocking IGF1R
function (using JB1) indicates that inhibition of IGF1R strongly reduces NSC proliferation,
exceeding the effect of IGF2 knockdown alone. Arrowheads point to EdU/GFP-labeled
cells. Data are presented as mean ± s.e.m. Scale bar represents 50 μm. ** p < 0.01, * p <
0.05
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Figure 5.
IGF2 functions predominantly in an autocrine manner. Co-cultured DG NSCs transduced
with shRNA-expressing viruses (control and shRNA-expressing virus in green) were plated
in three ratios (>90% upper panel, ~70% middle panel, <25% lower panel) together with
non-transduced DG-derived NSCs. Proliferation of transduced and non-transduced cells was
measured by EdU labeling (red). High ratios of IGF2-knockdown cells (>90% of all cells)
affected the proliferation rate of non-transduced cells, whereas at lower rates no differences
could be detected compared to control. Arrowheads point to GFP-expressing, EdU-labeled
cells. Data are presented as mean ± s.e.m. Scale bar represents 50 μm. * p < 0.05
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Figure 6.
IGF2 knockdown reduces NSC proliferation in the adult DG. A, Fluorescence intensity
measurements of IGF2 staining in either non-targeting shRNA or shRNA against Igf2-
infected cells. Shown are confocal images of the DG after injection of a control virus
expressing a non-targeting shRNA (CON, green, upper panels) or virus expressing shRNA
against Igf2 (Igf2-sh1, green, lower panels) and stained for IGF2 (red, left panels).
Quantification of the IGF2 staining in virus-transfected cells of the DG, showing a reduction
in the relative fluorescence level in the Igf2 knockdown cells compared to the CON shRNA
cells. B, Shown are confocal images of the DG after injection of a control virus expressing a
non-targeting shRNA (green, upper panels) or virus expressing shRNA against Igf2 (Igf2-
sh1, green, lower panels). Proliferating cells in the DG were visualized by IdU labeling
(red). Note the reduction in IdU-labeled cells in the DG. Right panels show an overlay of
single channels. C, Shown are confocal images of the SVZ after injection of a control virus
(green, upper panels) or virus expressing shRNA against Igf2 (Igf2-sh1, green, lower
panels). Right panels show an overlay of single channels. In contrast to the DG, IGF2
knockdown does not impair proliferation in the SVZ. Data are presented as mean ± s.e.m.
Scale bars represent 100 μm. * p < 0.05
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